Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial.

A. F. Cicero, G. Derosa, R. Brillante, R. Bernardi, S. Nascetti, A. Gaddi

Research output: Contribution to journalArticle

Abstract

An unspecific feeling of fatigue and asthenia often pushes elderly patients to require any form of help even from non medically trained people. Traditional Chinese medicine suggest that Siberian ginseng could act as safe "adaptogenic" substance. Our aim was thus to test the effect of a middle term Eleutherococcus senticosus Maxim. (Araliaceae) administration on elderly, health related quality of life (HRQOL). 20 elderly hypertensive and digitalized volunteers (age >/= 65 years) were randomized in a double -blind manner to E. senticosus dry extract 300 mg/day (n = 10) or placebo (n = 10) for 8 weeks. The short form-36 health survey version 2 (SF-36v2), a validated general health status questionnaire, was used to access HRQOL at baseline and at 4 and 8 weeks. There were no significant differences in baseline demographics and SF-36v2 scores between the groups. At each visit, controls of digitalemia and blood pressure level were carried out. After 4 weeks of therapy, higher scores in social functioning (p = 0.02) scales were observed in patients randomized to E. senticosus; these differences did not persist to the 8-week time point. No adverse event has been observed in both groups of patients. No significant difference in both blood pressure control and digitalemia was observed in both treatment groups. Subjects give E. senticosus (70%) were more likely to state that they received active therapy than subjects given placebo (20%; p <0.05). In conclusion, E. senticosus safely improves some aspects of mental health and social functioning after 4 weeks of therapy, although these differences attenuate with continued use.

Original languageEnglish
Pages (from-to)69-73
Number of pages5
JournalArchives of gerontology and geriatrics. Supplement
Issue number9
Publication statusPublished - 2004

Fingerprint

Eleutherococcus
Randomized Controlled Trials
Quality of Life
Health Surveys
Araliaceae
Placebos
Blood Pressure
Asthenia
Chinese Traditional Medicine
Therapeutics
Health Status
Fatigue
Volunteers
Mental Health
Emotions
Demography

Cite this

Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life : a randomized clinical trial. / Cicero, A. F.; Derosa, G.; Brillante, R.; Bernardi, R.; Nascetti, S.; Gaddi, A.

In: Archives of gerontology and geriatrics. Supplement, No. 9, 2004, p. 69-73.

Research output: Contribution to journalArticle

@article{56b1da694b0b4eec9c225a76ca111379,
title = "Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial.",
abstract = "An unspecific feeling of fatigue and asthenia often pushes elderly patients to require any form of help even from non medically trained people. Traditional Chinese medicine suggest that Siberian ginseng could act as safe {"}adaptogenic{"} substance. Our aim was thus to test the effect of a middle term Eleutherococcus senticosus Maxim. (Araliaceae) administration on elderly, health related quality of life (HRQOL). 20 elderly hypertensive and digitalized volunteers (age >/= 65 years) were randomized in a double -blind manner to E. senticosus dry extract 300 mg/day (n = 10) or placebo (n = 10) for 8 weeks. The short form-36 health survey version 2 (SF-36v2), a validated general health status questionnaire, was used to access HRQOL at baseline and at 4 and 8 weeks. There were no significant differences in baseline demographics and SF-36v2 scores between the groups. At each visit, controls of digitalemia and blood pressure level were carried out. After 4 weeks of therapy, higher scores in social functioning (p = 0.02) scales were observed in patients randomized to E. senticosus; these differences did not persist to the 8-week time point. No adverse event has been observed in both groups of patients. No significant difference in both blood pressure control and digitalemia was observed in both treatment groups. Subjects give E. senticosus (70{\%}) were more likely to state that they received active therapy than subjects given placebo (20{\%}; p <0.05). In conclusion, E. senticosus safely improves some aspects of mental health and social functioning after 4 weeks of therapy, although these differences attenuate with continued use.",
author = "Cicero, {A. F.} and G. Derosa and R. Brillante and R. Bernardi and S. Nascetti and A. Gaddi",
year = "2004",
language = "English",
pages = "69--73",
journal = "Archives of gerontology and geriatrics. Supplement",
issn = "0924-7947",
publisher = "Elsevier BV",
number = "9",

}

TY - JOUR

T1 - Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life

T2 - a randomized clinical trial.

AU - Cicero, A. F.

AU - Derosa, G.

AU - Brillante, R.

AU - Bernardi, R.

AU - Nascetti, S.

AU - Gaddi, A.

PY - 2004

Y1 - 2004

N2 - An unspecific feeling of fatigue and asthenia often pushes elderly patients to require any form of help even from non medically trained people. Traditional Chinese medicine suggest that Siberian ginseng could act as safe "adaptogenic" substance. Our aim was thus to test the effect of a middle term Eleutherococcus senticosus Maxim. (Araliaceae) administration on elderly, health related quality of life (HRQOL). 20 elderly hypertensive and digitalized volunteers (age >/= 65 years) were randomized in a double -blind manner to E. senticosus dry extract 300 mg/day (n = 10) or placebo (n = 10) for 8 weeks. The short form-36 health survey version 2 (SF-36v2), a validated general health status questionnaire, was used to access HRQOL at baseline and at 4 and 8 weeks. There were no significant differences in baseline demographics and SF-36v2 scores between the groups. At each visit, controls of digitalemia and blood pressure level were carried out. After 4 weeks of therapy, higher scores in social functioning (p = 0.02) scales were observed in patients randomized to E. senticosus; these differences did not persist to the 8-week time point. No adverse event has been observed in both groups of patients. No significant difference in both blood pressure control and digitalemia was observed in both treatment groups. Subjects give E. senticosus (70%) were more likely to state that they received active therapy than subjects given placebo (20%; p <0.05). In conclusion, E. senticosus safely improves some aspects of mental health and social functioning after 4 weeks of therapy, although these differences attenuate with continued use.

AB - An unspecific feeling of fatigue and asthenia often pushes elderly patients to require any form of help even from non medically trained people. Traditional Chinese medicine suggest that Siberian ginseng could act as safe "adaptogenic" substance. Our aim was thus to test the effect of a middle term Eleutherococcus senticosus Maxim. (Araliaceae) administration on elderly, health related quality of life (HRQOL). 20 elderly hypertensive and digitalized volunteers (age >/= 65 years) were randomized in a double -blind manner to E. senticosus dry extract 300 mg/day (n = 10) or placebo (n = 10) for 8 weeks. The short form-36 health survey version 2 (SF-36v2), a validated general health status questionnaire, was used to access HRQOL at baseline and at 4 and 8 weeks. There were no significant differences in baseline demographics and SF-36v2 scores between the groups. At each visit, controls of digitalemia and blood pressure level were carried out. After 4 weeks of therapy, higher scores in social functioning (p = 0.02) scales were observed in patients randomized to E. senticosus; these differences did not persist to the 8-week time point. No adverse event has been observed in both groups of patients. No significant difference in both blood pressure control and digitalemia was observed in both treatment groups. Subjects give E. senticosus (70%) were more likely to state that they received active therapy than subjects given placebo (20%; p <0.05). In conclusion, E. senticosus safely improves some aspects of mental health and social functioning after 4 weeks of therapy, although these differences attenuate with continued use.

UR - http://www.scopus.com/inward/record.url?scp=5444268170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5444268170&partnerID=8YFLogxK

M3 - Article

C2 - 15207399

SP - 69

EP - 73

JO - Archives of gerontology and geriatrics. Supplement

JF - Archives of gerontology and geriatrics. Supplement

SN - 0924-7947

IS - 9

ER -